-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Board Transition
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®
-
-
-
-
-
-
-
ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
-
-
-
-
-
-
-
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
-
-
-
-
-
-
-
Truist Securities Downgrades ANI Pharmaceuticals (ANIP) to Hold
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

